Being Elderly Is Not a Predictive Factor of Discontinuation of Abatacept Due to Adverse Events in Rheumatoid Arthritis Patients with Concomitant Methotrexate: A Retrospective Observational Study Based on Data from a Japanese Multicenter Registry Study

被引：0
|
作者：
Takahashi, Nobunori [1 ]
Kojima, Toshihisa [1 ]
Asai, Shuji [1 ]
Watanabe, Tatsuo [1 ]
Matsumoto, Takuya [1 ]
Asai, Nobuyuki [1 ]
Sobue, Yasumori [1 ]
Ishiguro, Naoki [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Orthopaed Surg, Nagoya, Aichi, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
540
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Predictive factors for achieving low disease activity at 52 weeks after switching from tumor necrosis factor inhibitors to abatacept: results from a multicenter observational cohort study of Japanese patients
    Kojima, Toshihisa
    Takahashi, Nobunori
    Kaneko, Atsushi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Kato, Takefumi
    Watanabe, Tsuyoshi
    Hayashi, Masatoshi
    Shioura, Tomone
    Kanayama, Yasuhide
    Funahashi, Koji
    Asai, Shuji
    Yoshioka, Yutaka
    Terabe, Kenya
    Takemoto, Toki
    Asai, Nobuyuki
    Ishiguro, Naoki
    CLINICAL RHEUMATOLOGY, 2016, 35 (01) : 219 - 225
  • [42] Predictive Factors for Achieving Low Disease Activity at 52 Weeks after Switching from Tumor Necrosis Factor Inhibitors to Abatacept: Results from a Multicenter Observational Cohort Study of Japanese Patients
    Kojima, Toshihisa
    Takahashi, Nobunori
    Funahashi, Koji
    Asai, Shuji
    Takemoto, Toki
    Asai, Nobuyuki
    Watanabe, Tatsuo
    Ishiguro, Naoki
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [43] The association between age and adverse events due to biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis A retrospective cohort study
    Ikari, Yuzo
    Yajima, Nobuyuki
    Miwa, Yusuke
    MEDICINE, 2020, 99 (52)
  • [44] TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS AS AN OVERALL MEASURE OF TOLERANCE AND SAFETY OF JAK-INHIBITORS: AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS (THE "JAKPOT" STUDY).
    Nham, E.
    Aymon, R.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    Elkayam, O.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kearsley-Fleet, L.
    Kristianslund, E.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Pavelka, K.
    Pombo-Suarez, M.
    Rotar, Z.
    Santos, M. J.
    Courvoisier, D.
    Lauper, K.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 177 - 178
  • [45] COST-EFFECTIVENESS OF EARLY INITIATION OF ABATACEPT ON JAPANESE RHEUMATOID ARTHRITIS PATIENTS BASED ON THE AMPLE STUDY, USING IORRA REAL WORLD DATA
    Tanaka, E.
    Inoue, E.
    Shoji, A.
    Nilsson, J.
    Papagiannopoulos, C.
    Devender, D.
    Anazawa, Y.
    Yoshizawa, Y.
    Harigai, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1886 - 1887
  • [46] Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
    Philip J. Mease
    Désirée van der Heijde
    Chitra Karki
    Mei Liu
    Yujin Park
    Jeffrey D. Greenberg
    Rheumatology and Therapy, 2018, 5 : 537 - 550
  • [47] Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
    Mease, Philip J.
    van der Heijde, Desiree
    Karki, Chitra
    Liu, Mei
    Park, Yujin
    Greenberg, Jeffrey D.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 537 - 550
  • [48] Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
    Gulsen Ozen
    Sofia Pedro
    Rebecca Schumacher
    Teresa A. Simon
    Kaleb Michaud
    Arthritis Research & Therapy, 21
  • [49] Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
    Ozen, Gulsen
    Pedro, Sofia
    Schumacher, Rebecca
    Simon, Teresa A.
    Michaud, Kaleb
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [50] Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study
    Sekiguchi, Masahiro
    Fujii, Takao
    Matsui, Kiyoshi
    Murakami, Kosaku
    Morita, Satoshi
    Ohmura, Koichiro
    Kawahito, Yutaka
    Nishimoto, Norihiro
    Mimori, Tsuneyo
    Sano, Hajime
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) : 1974 - 1983
12345